Jeph Herrin

Yale University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Collaborators (7)

Edward Miller

Associated Professor of Medicine (Cardiology) & Radiology and Biomedical Imaging

Yale University

UNITED STATES

View details

Guillermo Umpierrez

Professor of Medicine

Emory University School of Medicine

UNITED STATES

View details

Rozalina McCoy

Associate Professor of Medicine

University of Maryland School of Medicine

UNITED STATES

View details

Kathy MacLaughlin

Associate Professor of Family Medicine

Mayo Clinic Rochester

UNITED STATES

View details

Joseph Ross

Professor

Yale University School of Medicine

UNITED STATES

View details

Yuan Lu

Assistant Professor

Yale University

UNITED STATES

View details

Joan Griffin

Professor

Mayo Clinic

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeph Herrin

Research Interests

Explore related searches

Contact this professor

Articles (10)

Evaluating Blood Pressure Response Patterns to Exercise Stress Testing

Impact of Interventions to Improve Human Papillomavirus Vaccine Uptake on Other Vaccines Due: A Secondary Analysis of a Randomized Trial

Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial

Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare Advantage Enrollees in the United States, 2011-2022

Heterogeneity of Cardiovascular Effects of Second‐Line Glucose‐Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk

Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice

Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk

Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy

Sex-specific associations between habitual snoring and cancer prevalence: insights from a US Cohort Study

Prevalence, Severity, and Co-Occurrence of SPPADE Symptoms in 31,866 Patients With Cancer

Collaborators (7)

Edward Miller

Guillermo Umpierrez

Rozalina McCoy

Kathy MacLaughlin

Joseph Ross

Yuan Lu

Joan Griffin

Make your next move.